For: | Hu YH, Liu M, Yi W, Cao YJ, Cai HD. Tenofovir rescue therapy in pregnant females with chronic hepatitis B. World J Gastroenterol 2015; 21(8): 2504-2509 [PMID: 25741161 DOI: 10.3748/wjg.v21.i8.2504] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i8/2504.htm |
Number | Citing Articles |
1 |
Soheil Tavakolpour, Mohammad Darvishi, Hajar Sadat Mirsafaei, Mojtaba Ghasemiadl. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review. Infectious Diseases 2018; 50(2): 95 doi: 10.1080/23744235.2017.1384957
|
2 |
Bárbara Costa, Maria João Gouveia, Nuno Vale. Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics. Vaccines 2024; 12(7): 782 doi: 10.3390/vaccines12070782
|
3 |
Xuesong Gao, Xuefei Duan, Haodong Cai, Yuhong Hu, Min Liu, Kai Kang, Mingfang Zhou, Dong Fu, Wei Yi. The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2020; 32(12): 1533 doi: 10.1097/MEG.0000000000001662
|
4 |
Murat Afyon, Cumhur Artuk. Perinatal Hepatitis B Virüs Bulaşı. Arşiv Kaynak Tarama Dergisi 2016; 25(22109): 304 doi: 10.17827/aktd.237672
|
5 |
M. H. Hyun, Y.‐S. Lee, J. H. Kim, J. H. Je, Y. J. Yoo, J. E. Yeon, K. S. Byun. Systematic review with meta‐analysis: the efficacy and safety of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus. Alimentary Pharmacology & Therapeutics 2017; 45(12): 1493 doi: 10.1111/apt.14068
|
6 |
Jun-Ze Chen, Zuo-Wei Liao, Fei-Long Huang, Ru-Kui Su, Wen-Bo Wang, Xue-Yuan Cheng, Jie-Qing Chen, Jia-Qi Liu, Zhong Huang. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04479-x
|
7 |
Kumar Visvanathan, Geoff Dusheiko, Michelle Giles, May-Ling Wong, Nghi Phung, Susan Walker, Suong Le, Seng Gee Lim, Ed Gane, Meng Ngu, Winita Hardikar, Ben Cowie, Scott Bowden, Simone Strasser, Miriam Levy, Joe Sasaduesz. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut 2016; 65(2): 340 doi: 10.1136/gutjnl-2015-310317
|
8 |
Alberto Enrico Maraolo, Ivan Gentile, Antonio Riccardo Buonomo, Biagio Pinchera, Guglielmo Borgia. Current evidence on the management of hepatitis B in pregnancy. World Journal of Hepatology 2018; 10(9): 585-594 doi: 10.4254/wjh.v10.i9.585
|
9 |
Mimi Tin-Yan Seto, Ka Wang Cheung. Comprehensive Guide to Hepatitis Advances. 2023; : 629 doi: 10.1016/B978-0-323-98368-6.00032-X
|
10 |
Joseph L. Mathew, Bindiya Gupta, Deepak Chawla. Tenofovir for prevention of mother-to-child transmission of hepatitis B. Indian Pediatrics 2016; 53(10): 907 doi: 10.1007/s13312-016-0957-2
|
11 |
Yao Hu, Hui Yu. Prevention strategies of mother‐to‐child transmission of hepatitis B virus (HBV) infection. Pediatric Investigation 2020; 4(2): 133 doi: 10.1002/ped4.12205
|
12 |
H. Dilek DOĞAN, Çisem BAŞTARCAN. HEPATİT B PREVALANSINDAKİ GİZEM: HEPATİT B ve GEBELİK. Izmir Democracy University Health Sciences Journal 2021; 4(1): 118 doi: 10.52538/iduhes.923716
|
13 |
Sirinart Sirilert, Theera Tongsong. Hepatitis B Virus Infection in Pregnancy: An Update on Evidence-Based Management. Obstetrical & Gynecological Survey 2020; 75(9): 557 doi: 10.1097/OGX.0000000000000831
|
14 |
Norah A. Terrault, Miriam T. Levy, Ka Wang Cheung, Gonzague Jourdain. Viral hepatitis and pregnancy. Nature Reviews Gastroenterology & Hepatology 2021; 18(2): 117 doi: 10.1038/s41575-020-00361-w
|
15 |
Ka Wang Cheung, Mimi Tin Yan Seto, Terence Tzu-Hsi Lao. Prevention of perinatal hepatitis B virus transmission. Archives of Gynecology and Obstetrics 2019; 300(2): 251 doi: 10.1007/s00404-019-05190-0
|
16 |
Calvin Q Pan. The role of tenofovir disoproxil fumarate for preventing vertical transmission of hepatitis B. Antiviral Therapy 2022; 27(2) doi: 10.1177/13596535221076640
|
17 |
Kalyan Ram Bhamidimarri, Calvin Q. Pan. Update in the Management of Chronic Hepatitis B in Pregnancy. Current Hepatology Reports 2018; 17(4): 475 doi: 10.1007/s11901-018-0437-3
|
18 |
Jodie Dionne-Odom, Gabriella D. Cozzi, Ricardo A. Franco, Basile Njei, Alan T.N. Tita. Treatment and prevention of viral hepatitis in pregnancy. American Journal of Obstetrics and Gynecology 2022; 226(3): 335 doi: 10.1016/j.ajog.2021.09.002
|
19 |
|
20 |
Yayun Lin, Yan Liu, Guifeng Ding, Lhousseine Touqui, Weimin Wang, Na Xu, Keying Liu, Lingyan Zhang, Dunjin Chen, Yongzheng Wu, Guiqin Bai. Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33833-w
|
21 |
Bircan Kayaaslan, Rahmet Guner. Adverse effects of oral antiviral therapy in chronic hepatitis B. World Journal of Hepatology 2017; 9(5): 227-241 doi: 10.4254/wjh.v9.i5.227
|
22 |
Jing Wang, Jinfeng Liu, Caijing Qi, Taotao Yan, Furong Cao, Li Jin, Yingli He, Yuan Yang, Shulin Zhang, Tianyan Chen, Yingren Zhao. Efficacy of Tenofovir Disoproxil Fumarate to Prevent Vertical Transmission in Mothers with Lamivudine-Resistant HBV. Antiviral Therapy 2015; 20(7): 681 doi: 10.3851/IMP2981
|